The Inhalation Anesthesia Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The inhalation anesthesia market has experienced substantial growth in the past years. The market size is projected to escalate from $1.54 billion in 2024 to $1.65 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
The inhalation anesthesia market is predicted to expand to a size of $2.34 billion by 2029, with a compound annual growth rate (CAGR) of 9.1%.
Download Your Free Sample of the 2025 Inhalation Anesthesia Market Report and Uncover Key Trends Now!The key drivers in the inhalation anesthesia market are:
• Rising demand for minimally invasive surgeries
• Increasing global expenditure on healthcare
• Greater adoption of inhalation anesthesia in veterinary medicine
• Increased government funding for research and development of innovative inhalation anesthetics
The inhalation anesthesia market covered in this report is segmented –
1) By Product: Sevoflurane, Desflurane, Isoflurane, Nitrous Oxide
2) By Application: Induction, Maintenance
3) By End User: Hospitals, Ambulatory Surgical Centers
The key trends in the virtualization security market are:
• The ongoing shift towards the use of sevoflurane and desflurane is an emerging trend in the market.
• Technological advancements, particularly in delivery systems for anesthesia, are shaping the market's future.
• The development and use of inhalation anesthesia devices designed specifically for pediatric use is becoming a significant trend.
• There is an increasing focus on the use and development of eco-friendly anesthetic agents.
Major companies in the inhalation anesthesia market are:
• Abbvie Inc.
• Baxter International Inc.
• Fresenius SE & Co. KGaA
• Halocarbon Products Corporation
• Hikma Pharmaceuticals PLC
• B. Braun Melsungen AG
• Lunan Pharmaceutical Group Co. Ltd.
• Maruishi Pharmaceutical Co. Ltd.
• Mylan N. V.
• Piramal Enterprises Ltd.
• Recipharm AB
• Sandoz International GmbH
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Wockhardt Ltd.
• AstraZeneca PLC
• C. H. Boehringer Sohn AG & Co. KG
• Eisai Co. Ltd.
• GlaxoSmithKline PLC
• Johnson & Johnson Inc.
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S. A.
• Takeda Pharmaceutical Company Limited
• Teijin Pharma Limited
• UCB S. A.
• Zydus Lifesciences Limited
North America was the largest region in the inhalation anesthesia market in 2024